When it comes to labeling unexpected events during a clinical trial, most investigators agree: The answer isn’t always obvious. The definitions – and the required responses -- vary from one agency to the next.
And the reporting process only adds more stress. Misjudge a problem and you’ll pay a steep price for failure to report to the FDA.
Clinical Trials Adverse Event Reporting Reference Guide is the most up-to-date, comprehensive collection of rules, regulations and guidances available in a murky area where change happens fast.
The first edition of the Guide sold out. But, that was three years ago. Look at all that has changed:
A newly issued guidance from OHRP on IRB Continuing Review of Research
Another new guidance on Reporting Incidents to OHRP
A new FDA guidance, Safety Reporting Requirements for INDs and BA/BE Studies
Plus numerous new enforcement cases involving adverse event reporting
The Clinical Trials Adverse Event Reporting Reference Guide, Second Edition provides official OHRP and FDA answers to nagging questions, including:
How to determine if an adverse event needs to be reported
When does an expected adverse event become an unanticipated adverse event
How do adverse events differ from unanticipated problems
How to assess if an event is unexpected
How to assess whether an event is related to research
What needs to be included in adverse event reports
And much more
Also featured — analysis of relevant warning letters, illustrating ways adverse event reporting requirements often are misconstrued or overlooked.
Whether you’re in drugs or devices ... a CRO or a clinical trial site operator ... the Clinical Trials Adverse Event Reporting Reference Guide, Second Edition belongs on your bookshelf or desk, in easy reach. When those tough calls arise, you’ll find yourself referring to it again and again.
Clinical Trials Adverse Event Reporting Reference Guide, Second Edition is available in print (200+ pp.) or PDF format for $377 each. Act now: place your order here.
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your publication? Return the hard copy within 30 days (in resalable condition), and we will refund 100 percent of your purchase price (less shipping/handling). For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund.
Interested in purchasing more than one print copy?
Significant volume discounts are available for ordering three or more copies of the same book. You must order them at the same time and provide a single payment to take advantage of the discount. Order below by clicking submit and then change your quantity in the shopping cart. The discount will be calculated automatically.
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally with any questions.
Interested in Electronic Multi-user Access?
Phone: +1 (703) 538-7600 or toll free (888) 838-5578